VasopressinHormone TherapySafety Rating 9/10

Primary research areaVasodilatory shock

Research-literature reference data, NOT patient instructions. Not for human use. Consult a licensed clinician for any human application.

Research dose range0.01-0.1 units/min IV infusion
AdministrationIntravenous
Safety9/10 · FDA-approved (Vasostrict)
NCAA D1Not listed

Price Comparison

Compare vendors

No vendor pricing available for this peptide yet.

Overview

About Vasopressin

Mechanism of action

V1/V2 receptor agonist; vasoconstriction and antidiuretic effect

Safety profile

Hypertension, cardiac ischemia, hyponatremia · Essential critical care medication; decades of safe use; well-characterized

📈

Price tracking starts now.

Set an alert to get notified when this peptide drops.

Related pages

More on Vasopressin

Failed to fetch